Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China

• Главные авторы: Wen Zeng (Автор), Ning Liu (Автор), Yuchun Li (Автор), Ai Gao (Автор), Mengyi Yuan (Автор), Rui Ma (Автор), Na Jiang (Автор), Dingwei Sun (Автор), Guangze Wang (Автор), Xinyu Feng (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) during treatment. The different prevalence and distribution patterns of G6PDd in...